COL22A1 and cancer: Given that COL22A1 is known for its role in ECM organization and has been associated with tumor progression in other studies (31, 32), It is plausible that COL22A1 could similarly influence the structural and functional dynamics of the ECM, potentially affecting interactions between immune cells and cancer cells.